Literature DB >> 1581122

Epidemiology of osteoporosis.

J A Kanis1, F A Pitt.   

Abstract

Fragility fractures are now recognised as a major problem of public health. Although the prevalence of all fractures is similar among men and women, the vast majority of osteoporotic fractures occur in elderly women. These comprise vertebral compression fractures, Colles fractures at the wrist, and hip fracture, and to a lesser extent fractures at other sites. The incidence of vertebral and hip fracture increases exponentially with age. The reasons for this relate in part to the lower bone density of women at the time of maturity (peak bone density), and the accelerated bone loss that occurs after the menopause. Women live significantly longer than men, so that the prevalence of osteoporosis amongst elderly women is six-fold that of men. The age- and sex-specific incidence of osteoporotic fracture is rising in many countries, and if the current trends in the United Kingdom continue, then the number of hip fractures each year will more than double over the next 20 years. There is a marked geographic distribution in the incidence of hip fracture, and probably of other osteoporotic fractures. Indeed, the difference in incidence between communities is greater than the difference in incidence between sexes within communities. This suggests that the importance of gonadal insufficiency in women has been over-emphasised and that other factors, probably relating to life-style factors affecting peak bone density, account for ecological differences in incidence between communities and secular trends within communities.

Entities:  

Mesh:

Year:  1992        PMID: 1581122     DOI: 10.1016/s8756-3282(09)80004-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  58 in total

Review 1.  The burden of osteoporosis.

Authors:  J A Kanis; O Johnell
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  [Vertebroplasty in severe osteoporosis. Technique and experience with multi-segment injection].

Authors:  P F Heini; R Orler
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

3.  Familial correlation of bone mineral density, birth data and lifestyle factors among adolescent daughters, mothers and grandmothers.

Authors:  Hiroaki Ohta; Tatsuhiko Kuroda; Yoshiko Onoe; Chie Nakano; Remi Yoshikata; Ken Ishitani; Kazunori Hashimoto; Miyoko Kume
Journal:  J Bone Miner Metab       Date:  2010-04-21       Impact factor: 2.626

4.  Direct clinical and welfare costs of osteoporotic fractures in elderly men and women.

Authors:  A Randell; P N Sambrook; T V Nguyen; H Lapsley; G Jones; P J Kelly; J A Eisman
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

5.  Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women.

Authors:  A H Holmberg; O Johnell; P M Nilsson; J Nilsson; G Berglund; K Akesson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

6.  Percutaneous vertebroplasty in the therapy of osteoporotic vertebral compression fractures: a critical review.

Authors:  K Hochmuth; D Proschek; W Schwarz; M Mack; A A Kurth; T J Vogl
Journal:  Eur Radiol       Date:  2006-03-16       Impact factor: 5.315

7.  Quality of life and vertebral osteoporosis.

Authors:  J A Kanis; W H Minne; P J Meunier; R Ziegler; E Allender
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

8.  Lordoplasty: report on early results with a new technique for the treatment of vertebral compression fractures to restore the lordosis.

Authors:  Rene Orler; Lars H Frauchiger; Uta Lange; Paul F Heini
Journal:  Eur Spine J       Date:  2006-05-25       Impact factor: 3.134

9.  Epidemiology of hip and wrist fractures in Cameroon, Africa.

Authors:  Roger Martin Djoumessi Zebaze; Ego Seeman
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

Review 10.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.